Company news
Pao Group, Inc. (OTC:PAOG) news
Pao Group, Inc. news releases on 6ix. Latest, Feb 18, 2021: PAOG Expects To Add CBD Nutraceuticals Revenue This Year
Press releases — page 3
PAOG Expects To Add CBD Nutraceuticals Revenue This Year
February 18, 2021
PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule
February 9, 2021
PAOG To Extend CBD Nutraceuticals Reach Into $3.8 Billion Market
February 4, 2021
PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B
February 3, 2021
PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary
February 3, 2021
PAOG CBD Nutraceuticals Underdevelopment To Be Distributed Through USMJ
January 27, 2021
PAOG Takes Next Step To Produce Cannabis Nutraceuticals
January 27, 2021
PAOG Sets 2021 Cannabis Biopharmaceutical Revenue Goals
January 14, 2021
PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment
January 5, 2021
PAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product Line
December 18, 2020
This Week on MoneyTV with Donald Baillargeon, 11/25
November 24, 2020
PURA and ALKM Cement Innovative Hemp Marketing Partnership With Equity Stake
November 23, 2020
PAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend Distribution
November 17, 2020
PAOG Confirms CBD Pharmaceutical Partnership With New PURA Hemp Initiative
November 12, 2020
PAOG Hemp Cultivation Partnership In Texas Begins On News Of First Hemp Harvest In 80 Years
November 9, 2020
PAOG To Welcome PURA Shareholders As New PAOG Shareholders Through Dividend Distribution
October 30, 2020
PAOG Adds Nutraceutical Pathway To Pharmaceutical Cannabis Strategy
October 29, 2020
PURA Reports Major Headway On New Hemp Lifestyle Brand; Confirms Dividend Update
October 29, 2020
PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval
October 23, 2020
PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research
October 20, 2020
PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday
October 20, 2020
PAOG Expects To Finalize CRO Engagement For Cannabis Drug Within Next Two Weeks
October 15, 2020
PAOG Advances Independent Research of Cannabis Drug RespRx
October 7, 2020
PAOG Announces CEO Interview Discussing Cannabis Investigational New Drug Application Plans With FDA
October 2, 2020
PAOG Announces New Engagement To Prepare For Investigational New Drug Application With FDA
October 1, 2020
PAOG Sees Broader Cannabis Pharma Treatment Opportunity
September 24, 2020
PAOG CBD Pharma Development Initiative In Puerto Rico Could Get Boost From COVID-19
September 17, 2020
PAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site
September 16, 2020
PAOG Takes CBD Pharmaceutical Research Global To Target $5.8 Billion Market
September 15, 2020
PAOG CEO on MoneyTV This Friday Discussing Latest CBD Bio Pharma Developments
September 14, 2020
PAOG Announces Analyst Report Update With $0.015 PPS 12-Month Target For New Cannabis Pharma Business
September 8, 2020
PAOG Announces OTC Markets Current Information Reporting Standard
September 2, 2020
PAOG Announces New Interim CEO, Highlights Filing of Recent Supplemental Information
September 12, 2019
PAOG Hosts Meet-and-Greet Booth at HIGH TIMES Cannabis Cup in Detroit, MI, August 17-18. Launch of HIGH END Products Brand and CBD Only Cannophen(TM)
July 29, 2019
PAO Group, Inc. Debuted Cannophen™ at the HIGH TIMES Cannabis Cup Michigan
June 17, 2019
PAO GROUP INC Announces Indoor Grow and Lab Acquisition, CHAMPS Tradeshow Attendance and CMO Appointment
March 12, 2019
PAOG Officially Appoints Karl Riedel as New CEO and President
February 10, 2019
PAO Group, Inc. Announces Michigan 1,500 Plant Grower License Application
January 28, 2019
PAO Group Holds Shareholder Conference Call with Incoming CEO to Share His Vision for the Company
January 22, 2019
Alternative Medicine Centers of America™ Growing in Green States at Record Pace with New Locations in Pennsylvania, Ohio and Florida; Sites Set on Capturing a Piece of the $9 Billion Industry
July 2, 2018
PAO MMJ Alternative Medicine Centers of America™ Positioned for Explosive Growth with Exclusive Corporate Ownership on All Locations
June 11, 2018
PAO Group Continues National Expansion with Acclaimed MMJ Alternative Medicine Centers of America™
April 23, 2018
PAO Group, Inc. Announces Corporate Buyout Initiatives and Opiate Addiction Care Toward Greater Shareholder Value, Quality of Care and Overall Profitability
February 20, 2018
PAO Group, Inc. Takes on Opioid Crisis with Free Naloxon Classes for the Public; Announces Lease Agreement LOIs for State Approved Medical Cannabis Dispensaries alongside Positive 3rd Quarter Financials
November 21, 2017
Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum
September 29, 2017
PAO Group, Inc. Announces New Location Openings, Expansion initiative in Michigan, Pennsylvania and Arkansas
September 14, 2017
PAO Group, Inc. Announces Profitable Q2, New Corporate Location Openings and Expands Staffing Agreement with Physicians Group
July 31, 2017
PAO Group, Inc. Announces Name and Ticker Change Alongside Opening of New Corporate Locations
July 13, 2017
New Wave Holdings, Inc.'s PAO Group Launches Two New Corporate Locations in Ohio
June 26, 2017
PAO Group, Inc. Releases Q1 Financials Demonstrating Revenues; Details Shareholder Conference Call with Anticipated Near-Term Growth
May 16, 2017